AVXL
Anavex Life Sciences Corp
2.40$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -75.0% | +9,233.3% | +7.1% | -99.5% | +3,024.4% | +392.7% | – | – | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +54.2% | +44.6% | +27.5% | -4.8% | +2.2% | -90.1% | +177.6% | +210.2% | +219.3% | +47.1% | +25.0% | +66.8% | +13.3% | +30.7% | +15.0% | +15.3% | -4.3% | -10.1% | |
| – | – | – | +2,326.7% | +513.1% | -31.6% | +12.3% | +18.1% | -54.9% | +20.4% | +19.7% | +116.3% | +72.3% | -39.9% | +19.6% | +14.3% | -14.5% | +54.0% | +44.9% | -7.9% | -8.3% | +25.2% | |
| – | +532.8% | -72.0% | +6,065.9% | +234.0% | -10.2% | +19.2% | +9.6% | -30.2% | -50.6% | +39.2% | +139.4% | +109.3% | +4.5% | +23.5% | +50.2% | +7.9% | +35.1% | +21.4% | +9.4% | -5.2% | -2.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -45.0% | +2,776.5% | +246.9% | +404.3% | +404.4% | -69.1% | +59.9% | -64.4% | -86.2% | +913.2% | +15,663.3% | -100.0% | – | +388.4% | +3,080.0% | -16.0% | -76.6% | +1.8% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.5% | – | – | +2,364.6% | +838.9% | +310.5% | -64.1% | +253.7% | -98.7% | -86.2% | +913.2% | -58.8% | +101.3% | +22.0% | +13.0% | -5,396.1% | – | +33.6% | -102.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.